Immuron Limited (IMRN)
NASDAQ: IMRN
· Real-Time Price · USD
1.90
0.10 (5.56%)
At close: Sep 10, 2025, 2:15 PM
5.56% (1D)
| Bid | 1.89 |
| Market Cap | 10.88M |
| Revenue (ttm) | 7.82M |
| Net Income (ttm) | -9.78M |
| EPS (ttm) | -0.6 |
| PE Ratio (ttm) | -3.17 |
| Forward PE | -94 |
| Analyst | Buy |
| Ask | 1.92 |
| Volume | 52,577 |
| Avg. Volume (20D) | 242,329 |
| Open | 1.84 |
| Previous Close | 1.80 |
| Day's Range | 1.84 - 1.90 |
| 52-Week Range | 1.50 - 2.87 |
| Beta | 0.50 |
About IMRN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol IMRN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for IMRN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts7 months ago
+8.59%
Immuron shares are trading higher after the compan...
Unlock content with
Pro Subscription
7 months ago
+1.52%
Immuron shares are trading higher after the company announced that it has submitted its Phase 2 study report to the FDA and is preparing for the the next steps toward its Phase 3 trial.
2 years ago · proactiveinvestors.co.uk
Immuron CEO highlights strong sales growth in business update presentationImmuron Ltd (NASDAQ:IMRN, ASX:IMC) CEO Steven Lydeamore highlighted the strong growth in sales of oral immunotherapeutic products in the company's February 2023 business update presentation for invest...
3 years ago · investorplace.com
IMRN Stock Alert: What Is the Huge Catalyst Sending Immuron Soaring?Today marks one of the best days for IMRN stock in a long time, with shares surging nearly 50% on the back of some impressive news. The post IMRN Stock Alert: What Is the Huge Catalyst Sending Immuron...
